CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents.
Antioxidants (Basel)
; 12(2)2023 Feb 15.
Article
in En
| MEDLINE
| ID: mdl-36830052